The Costs of Type 2 Diabetes Mellitus Outpatient Care in the Brazilian Public Health System

Bahia, Luciana; Araújo, Denizar Vianna; Schaan, Beatriz D.; Dib, Sérgio Atala; Negrato, Carlos Antônio; Leão, Marluce P.S.; Ramos, Aline Sharlon Maciel Batista; Forti, Adriana Costa e; Gomes, Marı́lia B.; Foss, Maria Cristina; Monteiro, Rosane Aparecida; Sartorelli, Daniela Saes; Franco, Laércio Joel

doi:10.1016/j.jval.2011.05.009

Cited by 134 publications

(143 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The indirect cost of DM per capita per mo estimated by Tharkar was INR 415 [8], closely resembling our study, whereas Bahia et al have reported a higher cost of INR 4278 [9]. The high cost reported by Bahia could be due to the inclusion of patients with complicated DM and hospitalization for assessment of COI.…”

Section: Discussionsupporting

confidence: 86%

Burden of Therapy in Patients Suffering From Diabetes Mellitus and Hypertension

Ramanna

Ruckmani

Janti

et al. 2017

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

Objective: To estimate a) monthly expenditure for treatment of diabetes mellitus (DM), hypertension (HTN) and both (DM+HTN) and b) economic burden (EB) and psychological burden (PB) of therapy of DM, HTN and DM+HTN.Methods: An observational questionnaire-based study was conducted among 180 patients. The monthly cost of drug therapy was assessed based on the drugs they were taking and the cost of individual drugs. The EB and PB were assessed using a validated questionnaire and data analysed by ANOVA followed by post hoc test.Results: Among 216 patients who were interviewed, 180 fulfilled the selection criteria. Among 180, 75 had DM, 40 HTN and 65 had both. Prevalence of DM and DM+HTN was higher among females and of HTN equal among males and females. The average total monthly cost of therapy for DM was INR 2077, for HTN INR 1464 and for DM+HTN INR 2269.Significant correlation was found between income and percentage of expenditure (p<0.001) in all the groups. The PB was found to correlate with low income (p<0.001), poor education (p<0.05) occupation (p<0.01) in DM+HTN and number of tablets (p<0.01) in DM and DM+HTN groups. Conclusion:The cost of therapy was higher for DM+HTN and DM. The percentage of expenditure was higher in low-income group and burden of therapy was directly proportional to the number of tablets, poor educational and occupational status; and inversely proportional to income.

show abstract

Section: Discussionsupporting

confidence: 86%

Burden of Therapy in Patients Suffering From Diabetes Mellitus and Hypertension

Ramanna

Ruckmani

Janti

et al. 2017

Int J Pharm Pharm Sci

View full text Add to dashboard Cite

show abstract

“…Estimates of the annual total cost of care with the diseased subject in Brazil reach more than two thousand dollars per patient, considering direct (medicine, tests, procedures and supplies, professional visits, and hospital expenses in emergency services, besides nonmedical expenses such as transportation and purchase of dietetic products) and indirect costs (absence at work, loss of productivity, and early retirement) 10 . RESUMO: Objetivo: Descrever medidas do cuidado assistencial destinadas ao paciente com diabetes mellitus autorreferido no Brasil.…”

Section: Introductionmentioning

confidence: 99%

Cuidados em saúde entre portadores de diabetes mellitus autorreferido no Brasil, Pesquisa Nacional de Saúde, 2013

Malta

Iser

Chueiri

et al. 2015

Rev. bras. epidemiol.

View full text Add to dashboard Cite

ABSTRACT:Objective: To describe the care measurements provided to patients with self-reported diabetes mellitus in Brazil. Methods: Data from the Brazilian National Health Survey (2013) were used. This is a crosssectional population-based study in which the subjects with self-reported diabetes mellitus answered questions concerning their use of health services and access to medicine. Results: The prevalence of self-reported diabetes mellitus was 6.2%, while 11.5% of the population had never undergone a glucose testing. From the adults with diabetes mellitus, 80.2% had taken medications two weeks before the interview, 57.4% used the Popular Pharmacy Program, 73.2% received medical care, and 47.1% were cared for in the Health Basic Units. In 65.2%, the physician who cared for them in the last appointment was the same from previous ones, 95.3% of the patients were able to perform the required complementary examinations, and 83.3% could go to the appointments with a specialist. About 35.6 and 29.1% of the subjects with diabetes mellitus reported feet and eyes examination, respectively. About 13.4% declared previous hospitalization owing to diabetes or any complications, and 7.0% mentioned limitations in their daily activities owing to the disease. In general, women and the elderly people, those with higher education levels, white, and those living in the south and southeastern regions showed a higher prevalence of the disease and greater access to services, medicine, and appointments. Discussion: The care reported by patients with diabetes, which is essential to maintain their quality of life and prevent serious outcomes, seemed, in most cases, to be adequate.

show abstract

“…13 Hence, little is known about the impact of T1DM alone. 12 Although previous studies have investigated the costs associated with diabetes in Brazil, 7,14 the impact of T1DM alone has never been assessed.…”

Section: Introductionmentioning

confidence: 99%